경피적 신장 결석 제거술 시장 : 제품 유형별, 시술 유형별, 환자별, 최종 용도별, 국가별, 지역별 - 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Percutaneous Nephrolithotomy market size was valued at US$ 1,580.2 Million in 2025, expanding at a CAGR of 7.7% from 2026 to 2033.

Percutaneous nephrolithotomy (PCNL) is a minimal surgical process that helps to get rid of kidney stones, also called renal calculi. In this procedure, a small opening is made in the skin, through which various instruments are used to disintegrate the stones and provide access to the kidney. Generally in those cases where other minimally invasive surgery techniques do not prove to be effective, such as lithotripsy using shock waves and ureteroscopy procedures, the PCNL technique becomes beneficial.

Three main kinds of PCNL are being employed, and these are, namely, the magnesium ammonium phosphate stone type, calcareous type, and uric acid calculus type. Main Components of Percutaneous Nephrolithotomy Accessories: The components, instruments and solutions that help in PCNL are procured by different hospitals, clinics and outpatient hospitals. Thus, the growing application of PCNL procedures has helped boost demand for stone removal devices and accessories.

Percutaneous Nephrolithotomy Market- Market Dynamics

Increasing prevalence of renal diseases to drive market expansion

The increasing prevalence of renal diseases is driving demand for percutaneous nephrolithotomy procedures, as there is the rising burden of stones in the kidneys and also of chronic kidney diseases, which make it necessary for the development of a procedure for stone removal, and PCNL is an effective standard procedure for handling large and complex kidney stones. For instance, in 2026, according to the Australian Institute of Health and Welfare (Org), an estimated 2.7 million Australians aged 18 years and above were estimated to have chronic kidney disease (CKD), which is 14.2% of the adult population in 2026. The rates of prevalence over time increased from 14% to 11.1% and 9.8%. With age, the burden of the disease increases; for those who are aged 75 years and older, the prevalence of CKD is 44.6%, whereas, for people aged between 18 and 44 years, it is only 7.2%. This rising disease burden is expected to increase demand for PCNL procedures for effective renal stone management.

Percutaneous Nephrolithotomy Market- Segmentation Analysis:

The Global Percutaneous Nephrolithotomy market is segmented on the basis of Product Type, Procedure Type, Patient, End Use, and Region.

The nephroscope segment is the key segment in the Percutaneous Nephrolithotomy market, as it is employed for use in PCNL, as it is used to help achieve viewing and visibility in the renal collecting system, which helps in the detection and removal of kidney stones and acts as an important driver in the market. In July 2026, OLYMPUS introduced the OES Pro Series of hybrid lens imaging percutaneous nephroscopes, which include the long working length and high-flow sheath technology, to aid in percutaneous nephroscopy and PCNL. These advanced nephroscopes enhance procedural efficiency, visualisation, and stone removal during minimally invasive treatments.

Percutaneous Nephrolithotomy Market- Geographical Insights

North America suffers from a high burden of kidney stones, which is related to obesity, high intake of sodium, inactive lifestyles, and consumption of animal protein and processed food. For instance, in July 2025, according to the National Kidney Foundation (Org), over 500,000 Americans go to hospitals every year due to kidney stones, and approximately 1 out of 10 (10%) of the population develops kidney stones in their lifetime. There has been a tremendous increase in the burden to about 10 people out of 100 (10%), compared to four out of 100 people (4%). It is estimated that 11% of men and 9% of women are estimated to have a stone annually. As indicated by the Kidney Foundation, 10 or more people in 100 will have more than one kidney stone at some point in their life" and 1/2 or 2 or more men and women will have one or more kidney stones. This growing and recurring disease burden is driving demand for PCNL procedures across North America.

Percutaneous Nephrolithotomy Market- Competitive Landscape:

The major companies working in the market of percutaneous nephrolithotomy have shifted their focus towards technology-based solutions that improve the accuracy and efficiency of the process. In addition to this, they are also trying to make their presence felt in the market through the use of nephroscopes, lithotripters, access kits and imaging systems. The major players in the market include Boston Scientific Corporation, Olympus Corporation, Cook Medical, Karl Storz SE & Co. KG, and Merit Medical Systems, all of whom are focusing on producing minimally invasive tools, digital endoscopy, and laser lithotripters. In March 2026, Boston Scientific Corporation was granted FDA approval for its Asurys(TM) Fluid Management System, an advanced irrigation management system for use in ureteroscopy, cystoscopy, percutaneous nephrolithotomy (PCNL), and BPH procedures. These advancements are expected to strengthen competition and accelerate innovation in the Percutaneous Nephrolithotomy market.

Recent Developments:

In March 2026, Dornier MedTech entered into a commercial alliance with Potent Medical, through which it has become the exclusive distributor of Holmium: YAG laser and Thulium fibre laser systems, which are used in urological procedures such as treating kidney stones in defined areas of Europe, the Americas, and the Asia-Pacific.

In September, 2025, Cook Medical strengthened its position in the urology category through a deal between Cook Medical and Vizient that helped in increased distribution of its range of urology products.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• B. Braun SE
• Becton, Dickinson and Company (BD)
• Coloplast A/S
• Teleflex Incorporated
• E.M.S. Electro Medical Systems S.A. (EMS)
• PolyDiagnost GmbH
• Allengers Medical Systems Limited
• Medispec Ltd.
• DirexGroup SA
• Pnn Medical A/S
• Potent Medical
• AngioDynamics, Inc.
• Argon Medical Devices, Inc.
• Terumo Corporation
• Zimmer Biomet Holdings, Inc.
• Envaste Limited
• Blue Neem Medical Devices Private Limited
• Boen Healthcare Co., Ltd.
• Others

GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

• Access systems
• Lithotripsy systems
• Nephroscopes
• Flexible
• Rigid
• Others

GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET, BY PROCEDURE TYPE- MARKET ANALYSIS, 2020 - 2033

• Micro-PCNL
• Standard PCNL
• Mini-PCNL

GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET, BY PATIENT- MARKET ANALYSIS, 2020 - 2033

• Pediatric
• Adult

GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033

• Hospitals
• Ambulatory surgery centers
• Others

GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Denmark
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Taiwan
• Vietnam
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Iran
• Qatar
• Rest of MEA

Table of Contents

1. Percutaneous Nephrolithotomy Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
• 2.2. Competitive Insights

3. Percutaneous Nephrolithotomy Key Market Trends

• 3.1. Percutaneous Nephrolithotomy Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Percutaneous Nephrolithotomy Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Percutaneous Nephrolithotomy Market Opportunities
• 3.4. Percutaneous Nephrolithotomy Market Future Trends

4. Percutaneous Nephrolithotomy Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Percutaneous Nephrolithotomy Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Percutaneous Nephrolithotomy Market Landscape

• 6.1. Percutaneous Nephrolithotomy Market Share Analysis, 2025
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Percutaneous Nephrolithotomy Market - By Product Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
  • 7.1.2. Access systems
  • 7.1.3. Lithotripsy systems
  • 7.1.4. Nephroscopes
    • 7.1.4.1. Flexible
    • 7.1.4.2. Rigid
  • 7.1.5. Others

8. Percutaneous Nephrolithotomy Market - By Procedure Type

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Procedure Type, 2025 & 2033 (%)
  • 8.1.2. Micro-PCNL
  • 8.1.3. Standard PCNL
  • 8.1.4. Mini-PCNL

9. Percutaneous Nephrolithotomy Market - By Patient

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Patient, 2025 & 2033 (%)
  • 9.1.2. Pediatric
  • 9.1.3. Adult

10. Percutaneous Nephrolithotomy Market - By End Use

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
  • 10.1.2. Hospitals
  • 10.1.3. Ambulatory surgery centers
  • 10.1.4. Others

11. Percutaneous Nephrolithotomy Market - By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Percutaneous Nephrolithotomy Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Percutaneous Nephrolithotomy Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.9. UK
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.9.4. UK Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.9.5. UK Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.3.9.6. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.10. France
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.10.4. France Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.10.5. France Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.3.10.6. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.11. Italy
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.11.4. Italy Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.11.5. Italy Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.3.11.6. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.12. Spain
    • 11.3.12.1. Overview
    • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.12.4. Spain Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.12.5. Spain Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.3.12.6. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.13. The Netherlands
    • 11.3.13.1. Overview
    • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.13.4. The Netherlands Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.13.5. The Netherlands Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.3.13.6. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Overview
    • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.3.14.6. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.15. Russia
    • 11.3.15.1. Overview
    • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.15.4. Russia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.15.5. Russia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.3.15.6. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.16. Poland
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.16.4. Poland Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.16.5. Poland Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.3.16.6. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.17. Denmark
    • 11.3.17.1. Overview
    • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.17.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.17.4. Denmark Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.17.5. Denmark Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.3.17.6. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.18. Rest of Europe
    • 11.3.18.1. Overview
    • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.18.5. Rest of the Europe Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.3.18.6. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Percutaneous Nephrolithotomy Key Manufacturers in Asia Pacific
  • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 11.4.5. APAC Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
  • 11.4.6. APAC Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
  • 11.4.7. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.8. China
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.8.4. China Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.8.5. China Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.4.8.6. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.9. India
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.9.4. India Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.9.5. India Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.4.9.6. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.13. Indonesia
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.13.4. Indonesia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.13.5. Indonesia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.14. Thailand
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.14.4. Thailand Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.14.5. Thailand Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.4.14.6. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.16. Taiwan
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.16.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.16.4. Taiwan Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.16.5. Taiwan Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.4.16.6. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.17. Vietnam
    • 11.4.17.1. Overview
    • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.17.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.17.4. Vietnam Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.17.5. Vietnam Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.4.17.6. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.18. Rest of APAC
    • 11.4.18.1. Overview
    • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.18.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.18.4. Rest of APAC Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.18.5. Rest of APAC Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.4.18.6. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
• 11.5. Latin America (LATAM)
  • 11.5.1. Overview
  • 11.5.2. Percutaneous Nephrolithotomy Key Manufacturers in Latin America
  • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 11.5.5. LATAM Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
  • 11.5.6. LATAM Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
  • 11.5.7. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
• 11.6. Middle East and Africa (MEA)
  • 11.6.1. Overview
  • 11.6.2. Percutaneous Nephrolithotomy Key Manufacturers in Middle East and Africa
  • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 11.6.5. MEA Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
  • 11.6.6. MEA Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
  • 11.6.7. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.14. Iran
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.14.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.14.4. Iran Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.14.5. Iran Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.6.14.6. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.15. Qatar
    • 11.6.15.1. Overview
    • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.15.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.15.4. Qatar Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.15.5. Qatar Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.6.15.6. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.16. Rest of MEA
    • 11.6.16.1. Overview
    • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.16.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.16.4. Rest of MEA Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.16.5. Rest of MEA Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 11.6.16.6. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Percutaneous Nephrolithotomy Industry

• 12.1. Competitive Benchmarking
  • 12.1.1. Competitive Dashboard
  • 12.1.2. Competitive Positioning
• 12.2. Company Profiles
  • 12.2.1. B. Braun SE
  • 12.2.2. Becton, Dickinson and Company (BD)
  • 12.2.3. Coloplast A/S
  • 12.2.4. Teleflex Incorporated
  • 12.2.5. E.M.S. Electro Medical Systems S.A. (EMS)
  • 12.2.6. PolyDiagnost GmbH
  • 12.2.7. Allengers Medical Systems Limited
  • 12.2.8. Medispec Ltd.
  • 12.2.9. DirexGroup SA
  • 12.2.10. Pnn Medical A/S
  • 12.2.11. Potent Medical
  • 12.2.12. AngioDynamics, Inc.
  • 12.2.13. Argon Medical Devices, Inc.
  • 12.2.14. Terumo Corporation
  • 12.2.15. Zimmer Biomet Holdings, Inc.
  • 12.2.16. Envaste Limited
  • 12.2.17. Blue Neem Medical Devices Private Limited
  • 12.2.18. Boen Healthcare Co., Ltd.
  • 12.2.19. Others

13. 360 Degree AnalystView

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us